IGF2BP1 and gastric cancer: A recent study revealed that not only IGF2BP1 can promote the proliferation, metastasis and prognosis of GC, but also facilitate its targeted mRNA c-MYC to accelerate glycolysis (also known as Warburg effect) in a m6A/c-MYC-dependent manner [39].